Spina Bifida Clinical Presentation
- Author: Mark R Foster, MD, PhD, FACS; Chief Editor: Elizabeth A Moberg-Wolff, MD more...
Myelomeningocele is diagnosed at birth or in utero. At birth, a midline defect in the posterior elements of the vertebrae is noted with protrusion of the meninges and neural elements through an external dural sac.
Although spina bifida occulta is common and almost always without consequence, some developmental abnormalities may occur—such as a spinal cord lipoma or a fibrous cord—that can cause subtle or rare neurologic signs.
A fibrous cord may extend from an interdural component of one of these developmental abnormalities to the skin, producing a dimple, an area of pigmentation, or a hairy patch at the base of the spine; such symptoms can be noted on physical examination.
Patients with a fibrous cord may have problems with micturition, or they may have subtle neurologic signs, such as a foot deformity (most commonly, a cavus foot). A prompt and thorough investigation is mandatory for any progressive neurologic signs. When a lipoma is present, there may be a lipomeningocele, a lipomyelomeningocele, or a lipomyelocele. These may be associated with areas of fluid in the cord, which may be a syringomyelia.
In general, infants with spina bifida cystica present with the following:
Ocular motor incoordination
Older children may present with the following:
Cognitive or behavioral changes
Changes in bowel or bladder function
Lower cranial nerve dysfunction
Worsening spinal or lower extremity orthopedic deformities
Some patients, however, may present with only papilledema. In any patient with myelomeningocele who presents with deterioration in neurologic, orthopedic, or urologic function, uncontrolled hydrocephalus should be excluded as a cause before any other treatment is pursued.
Chiari type II malformation
The Chiari type II malformation may cause acute or subacute signs and symptoms of lower brainstem and/or upper cervical spinal cord compression, including the following:
Laryngeal and pharyngeal paralysis
Upper extremity weakness
These problems rarely are severe. A varying degree of interference with cerebellar function seems to occur, particularly with balance and coordination, which has a significant influence on ambulation, the results of physical therapy, and overall orthopedic care.
Coordination and cognitive function
Failure to control a seizure disorder, recurrence of hydrocephalus, or even low pressure hydrocephalus can cause subtle coordination defects and interruption of some cognitive functions.
Tethered spinal cord
The tethered spinal cord may be signaled by foot deformities that previously braced easily, new onset of hip dislocation, or worsening of a spinal deformity, particularly scoliosis. Progressive neurologic defects in growing children may suggest a lack of extensibility of the spine or indicate that the spine is tethered and low-lying in the lumbar canal, with the potential for progressive, irreversible neurologic damage that requires surgical release.
The most obvious finding on physical examination is some degree of motor and sensory loss. Neurologic impairment is classified by traditional neurosegmental levels based on the clinically determined strength of specific muscle groups. The functional motor level does not always correspond to the anatomic level of the lesion.
In addition, it is important to realize that the motor paresis may be asymmetrical, that it may not correspond to the sensory level, and that it may result from a combination of upper and lower motor neuron lesions. Serial measurements and accurate documentation of the functional level of the lesion allow for early detection of progressive neurologic deterioration related to a variety of associated CNS problems.
In addition to determining the functional neurosegmental level, it is important to distinguish the type of paralysis, either spastic or flaccid. Most patients with myelomeningocele have a flaccid paraparesis below the spinal cord lesion.
An estimated 10-25% of patients have been reported to have a spastic paraparesis. This presentation is presumably related to an intact, but isolated, segment of cord distal to the lesion. Spastic paraparesis has been associated with a poorer prognosis for walking and higher rates of orthopedic procedures.
Neurosegmental levels and musculoskeletal complications
For the sake of general functional prognosis and anticipation of specific musculoskeletal complications, myelomeningocele patients frequently are classified as belonging to one of the following groups, based on the neurosegmental level of the lesion:
In the thoracic group, innervation of the upper limb and neck musculature and variable function of trunk musculature are present, with no volitional lower limb movements. Patients with thoracic malformations tend to have more involvement of the CNS and associated cognitive deficits.
In the high-lumbar group, variable hip flexor and hip adductor strength is characteristic. Absence of hip extension, hip abduction, and all knee and ankle movements is noted.
In the low-lumbar group, hip flexor, adductor, medial hamstring, and quadriceps strength is present. The strength of the lateral hamstrings, hip abductors, and ankle dorsiflexors is variable; the strength of the ankle plantar flexors is absent.
In the sacral-level group, strength of all hip and knee groups is present. Ankle plantar flexor strength is variable.
Complications of hydrocephalus
Involvement of the upper extremities is also common. Spasticity in the upper extremities occurs in approximately 20% of patients with myelomeningocele. It has been related to the number of shunts required to control hydrocephalus and has been shown to adversely affect independence in activities of daily living (ADL).
In patients with hydrocephalus, lack of upper extremity coordination is also seen. This lack of coordination also may be related to Chiari II malformation, motor-learning deficits, and/or delayed development of hand dominance. Affected children have problems with fine motor tasks, particularly when timed. New-onset weakness or spasticity in the upper extremities may be a hallmark of progressive neurologic dysfunction.
Spinal and lower extremity deformities
Spinal and lower extremity deformities and joint contractures are prevalent in children with myelomeningocele. Multiple factors may be involved, including intrauterine positioning, other congenital malformations, muscle imbalances, progressive neurologic dysfunction, poor postural habits, and reduced or absent joint motion.
Spinal deformities may be congenital or acquired. Vertebrae and rib anomalies are associated with congenital or early development of severe kyphotic and scoliotic deformities. Acquired scoliosis is neuromuscular in origin and is related to muscle imbalances. Increased lumbar lordosis and kyphosis of the entire spine or localized to the lumbar region are also observed. All of the spinal deformities occur more frequently in groups with higher spinal lesions.
Thoracic and high-lumbar lesions
The lower extremity deformities that occur are related to the functional level of the lesion. Thoracic and high-lumbar groups tend to have increased prevalences of the following:
Hip abduction and external rotation contractures
Equinus contractures of the ankles
Unopposed hip flexion and adduction contractures in the high-lumbar group frequently result in dislocated hips.
Mid- and low-lumbar lesions
The mid- and low-lumbar groups often have the following deformities:
Hip and knee flexion contractures
Increased lumbar lordosis
Genu valgus and calcaneal valgus malalignment
Patients in the sacral group often exhibit mild hip and knee flexion contractures and increased lumbar lordosis with various ankle and foot positions.
Children with myelomeningocele are often short in stature. This has been related to multiple factors, including the following:
Structural issues (eg, abnormalities of the spinal column and lower limb contractures)
Functional spinal level: This influences the amount of neurotrophic input from the lower extremities on appendicular skeletal growth
Alteration in the hypothalamic-pituitary axis, with associated growth hormone deficiency
Weight should be assessed in patients with spina bifida. Because of their decreased linear limb growth and spine growth, patients should be monitored for weight using arm-span measurements, as opposed to ratios of height versus weight. During growth spurts, patients require close monitoring for the development of any deformities, from scoliosis to deformities of the lower extremities.
Cranial nerve dysfunction
Symptoms of cranial nerve dysfunction include the following:
Ocular muscle palsies
Swallowing and eating problems
These symptoms may be related to the Chiari II malformation, hydrocephalus, and/or brainstem dysplasia.
Lower brainstem dysfunction
While symptoms are often mild, lower brainstem dysfunction is the leading cause of death in infants with myelomeningocele because of associated stridor, apnea, and aspiration pneumonitis. Common symptoms of lower brainstem dysfunction in infants include the following:
Swallowing or feeding difficulties
Frequent vomiting or gastroesophageal reflux
Older children and adults may present with the following:
Weakness or spasticity of the upper extremities
Headache or neck pain
Tethered spinal cord
A tethered spinal cord is caused by the tendency for the spinal cord to adhere to the meningocele repair and can prevent the normal cephalad migration of the cord during growth. A tethered cord is present anatomically in most children with myelomeningocele; the diagnosis of tethered cord syndrome is confirmed on the basis of clinical signs and symptoms, which can include pain, sensory changes, spasticity, and progressive scoliosis.
However, uncontrolled hydrocephalus and Chiari II malformation must be excluded as causes of these symptoms. Moreover, symptoms similar to those of tethered cord syndrome can also be caused by other intraspinal pathologies (eg, mass lesions of the cord, diastematomyelia, cord cavitation and narrowing, adhesions, dural bands).
Syringomyelia is caused by uncontrolled hydrocephalus that results in entry of cerebrospinal fluid (CSF) into the central canal of the spinal cord, causing dilatation and pressure. While this is a common MRI finding in patients with myelomeningocele, this condition is symptomatic in only 2-5% of cases. Symptoms described include the following:
Increasing weakness of the extremities
Vinck A, Nijhuis-van der Sanden MW, Roeleveld NJ, et al. Motor profile and cognitive functioning in children with spina bifida. Eur J Paediatr Neurol. 2010 Jan. 14(1):86-92. [Medline].
Thompson DN. Postnatal management and outcome for neural tube defects including spina bifida and encephalocoeles. Prenat Diagn. 2009 Apr. 29(4):412-9. [Medline].
Fletcher JM, Copeland K, Frederick JA, et al. Spinal lesion level in spina bifida: a source of neural and cognitive heterogeneity. J Neurosurg. 2005 Apr. 102(3 Suppl):268-79. [Medline].
McLone DG, Knepper PA. The cause of Chiari II malformations: a unified theory. Pediatr Neurosci. 1989. 15:1-12.
Ausili E, Focarelli B, Tabacco F, et al. Bone mineral density and body composition in a myelomeningocele children population: effects of walking ability and sport activity. Eur Rev Med Pharmacol Sci. 2008 Nov-Dec. 12(6):349-54. [Medline].
Wu YW, Croen LA, Henning L, et al. Potential association between infertility and spinal neural tube defects in offspring. Birth Defects Res A Clin Mol Teratol. 2006 Oct. 76(10):718-22. [Medline].
Canfield MA, Ramadhani TA, Shaw GM, et al. Anencephaly and spina bifida among Hispanics: maternal, sociodemographic, and acculturation factors in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol. 2009 Jul. 85(7):637-46. [Medline].
Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, Rothman KJ, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA. 1989 Nov 24. 262(20):2847-52. [Medline].
Centers for Disease Control and Prevention. Spina bifida and anencephaly before and after folic acid mandate--United States, 1995-1996 and 1999-2000. MMWR Morb Mortal Wkly Rep. 2004 May 7. 53(17):362-5. [Medline].
Holmes LB. Does taking vitamins at the time of conception prevent neural tube defects?. JAMA. 1988 Dec 2. 260(21):3181. [Medline].
Mulinare J, Cordero JF, Erickson JD, Berry RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA. 1988 Dec 2. 260(21):3141-5. [Medline].
Cotter AM, Daly SF. Neural tube defects: is a decreasing prevalence associated with a decrease in severity?. Eur J Obstet Gynecol Reprod Biol. 2005 Apr 1. 119(2):161-3. [Medline].
Centers for Disease Control and Prevention. Current Trends Economic Burden of Spina Bifida -- United States, 1980-1990. MMWR Morb Mortal Wkly Rep. Apr 21 1989;38(15):264-7. Available at http://www.cdc.gov/mmwr/preview/mmwrhtml/00001378.htm. Accessed: Mar 6 2014.
Canfield MA, Marengo L, Ramadhani TA, Suarez L, Brender JD, Scheuerle A. The prevalence and predictors of anencephaly and spina bifida in Texas. Paediatr Perinat Epidemiol. 2009 Jan. 23(1):41-50. [Medline].
Velie EM, Shaw GM, Malcoe LH, et al. Understanding the increased risk of neural tube defect-affected pregnancies among Mexico-born women in California: immigration and anthropometric factors. Paediatr Perinat Epidemiol. 2006 May. 20(3):219-30. [Medline].
Williams LJ, Rasmussen SA, Flores A, et al. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics. 2005 Sep. 116(3):580-6. [Medline].
Lindquist B, Uvebrant P, Rehn E, Carlsson G. Cognitive functions in children with myelomeningocele without hydrocephalus. Childs Nerv Syst. 2009 Aug. 25(8):969-75. [Medline].
Oakeshott P, Hunt GM, Poulton A, Reid F. Open spina bifida: birth findings predict long-term outcome. Arch Dis Child. 2012 May. 97(5):474-6. [Medline].
Lewis D, Tolosa JE, Kaufmann M, Goodman M, Farrell C, Berghella V. Elective cesarean delivery and long-term motor function or ambulation status in infants with meningomyelocele. Obstet Gynecol. 2004 Mar. 103(3):469-73. [Medline].
Danzer E, Gerdes M, Bebbington MW, et al. Lower extremity neuromotor function and short-term ambulatory potential following in utero myelomeningocele surgery. Fetal Diagn Ther. 2009. 25(1):47-53. [Medline].
Jackson EM, Schwartz DM, Sestokas AK, Zarnow DM, Adzick NS, Johnson MP, et al. Intraoperative neurophysiological monitoring in patients undergoing tethered cord surgery after fetal myelomeningocele repair. J Neurosurg Pediatr. 2014 Feb 7. [Medline].
Hoffer MM, Feiwell E, Perry R, Perry J, Bonnett C. Functional ambulation in patients with myelomeningocele. J Bone Joint Surg Am. 1973 Jan. 55(1):137-48. [Medline].
Barden GA, Meyer LC, Stelling FH 3rd. Myelodysplastics--fate of those followed for twenty years or more. J Bone Joint Surg Am. 1975 Jul. 57(5):643-7. [Medline].
Dicianno BE, Kinback N, Bellin MH, et al. Depressive symptoms in adults with spina bifida. Rehabil Psychol. 2015 Aug. 60 (3):246-53. [Medline].
McAndrew I. Adolescents and Young People with Spina Bifida, 1975-1976: A Study of the Physical Difficulties and Some of the Emotional Problems Faced by 35 Young People with Myelomengocele. Melbourne, Australia: Ability Press; 1977.
Anderson EM, Spain B. The Child with Spina Bifida. London, United Kingdom: Methuen; 1977.
Meeks JJ, Hagerty JA, Chaviano AH. Bulbar urethral ligation for managing persistent urinary incontinence in young men with myelomeningocele. BJU Int. 2009 Jul. 104(2):221-4. [Medline].
da Silva SA, de Almeida MF, Moron AF, Cavalheiro S, Dastoli PA, Guinsburg R. Resuscitation at birth in neonates with meningomyelocele. J Perinat Med. 2014 Jan. 42(1):113-9. [Medline].
Vachha B, Adams R. Implications of family environment and language development: comparing typically developing children to those with spina bifida. Child Care Health Dev. 2009 Sep. 35(5):709-16. [Medline].
Dias MS. Neurosurgical causes of scoliosis in patients with myelomeningocele: an evidence-based literature review. J Neurosurg. 2005 Jul. 103(1 Suppl):24-35. [Medline].
Fichter MA, Dornseifer U, Henke J, et al. Fetal spina bifida repair--current trends and prospects of intrauterine neurosurgery. Fetal Diagn Ther. 2008. 23(4):271-86. [Medline].
Adzick NS, Thom EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011 Mar 17. 364(11):993-1004. [Medline].
Jacobson LA, Tarazi RA, McCurdy MD, Schultz S, Levey E, Mahone EM, et al. The Kennedy Krieger Independence Scales-Spina Bifida Version: a measure of executive components of self-management. Rehabil Psychol. 2013 Feb. 58(1):98-105. [Medline].
Cancel D, Capoor J. Patient safety in the rehabilitation of children with spinal cord injuries, spina bifida, neuromuscular disorders, and amputations. Phys Med Rehabil Clin N Am. 2012 May. 23(2):401-22. [Medline].
Houtrow AJ, Maselli JH, Okumura MJ. Inpatient care for children, ages 1-20 years, with spina bifida in the United States. J Pediatr Rehabil Med. 2013. 6(2):95-101. [Medline].
Stubberud J, Langenbahn D, Levine B, Stanghelle J, Schanke AK. Goal management training of executive functions in patients with spina bifida: a randomized controlled trial. J Int Neuropsychol Soc. 2013 Jul. 19(6):672-85. [Medline].
Verhoef M, Barf HA, Post MW, van Asbeck FW, Gooskens RH, Prevo AJ. Functional independence among young adults with spina bifida, in relation to hydrocephalus and level of lesion. Dev Med Child Neurol. 2006 Feb. 48(2):114-9. [Medline].
Bier JA, Prince A, Tremont M, Msall M. Medical, functional, and social determinants of health-related quality of life in individuals with myelomeningocele. Dev Med Child Neurol. 2005 Sep. 47(9):609-12. [Medline].
Alman BA, Bhandari M, Wright JG. Function of dislocated hips in children with lower level spina bifida. J Bone Joint Surg Br. 1996 Mar. 78(2):294-8. [Medline].
Eichholzer M, Tönz O, Zimmermann R. Folic acid: a public-health challenge. Lancet. 2006 Apr 22. 367(9519):1352-61. [Medline].
Robbins JM, Tilford JM, Bird TM, et al. Hospitalizations of newborns with folate-sensitive birth defects before and after fortification of foods with folic acid. Pediatrics. 2006 Sep. 118(3):906-15. [Medline].
De Wals P, Tairou F, Van Allen MI, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med. 2007 Jul 12. 357(2):135-42. [Medline].
De Wals P, Tairou F, Van Allen MI, et al. Spina bifida before and after folic acid fortification in Canada. Birth Defects Res A Clin Mol Teratol. 2008 Sep. 82(9):622-6. [Medline].
Bell KN, Oakley GP Jr. Update on prevention of folic acid-preventable spina bifida and anencephaly. Birth Defects Res A Clin Mol Teratol. 2009 Jan. 85(1):102-7. [Medline].
Oakley GP Jr. The scientific basis for eliminating folic acid-preventable spina bifida: a modern miracle from epidemiology. Ann Epidemiol. 2009 Apr. 19(4):226-30. [Medline].
Humblet M, Verpoorten C, Christiaens MH, Hirche H, Jansen K, Buyse G, et al. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: With special reference to age-dependent parameters. Neurourol Urodyn. 2014 Jan 16. [Medline].